Patents by Inventor Clemens Ebner

Clemens Ebner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9969650
    Abstract: The invention concerns a batch for the production of a refractory magnesia-carbon product or a refractory alumina-magnesia-carbon product, a process for the production of a refractory magnesia-carbon product or a refractory alumina-magnesia-carbon product, a refractory magnesia-carbon product or a refractory alumina-magnesia-carbon product as well as the use of a magnesia-carbon product or a refractory alumina-magnesia-carbon product.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: May 15, 2018
    Assignee: REFRACTORY INTELLECTUAL PROPERTY GMBH & CO. KG
    Inventors: Clemens Ebner, Bernd Neubauer, Andreas Rief, Alexander Maranitsch, Bernd Trummer
  • Publication number: 20170305795
    Abstract: The invention concerns a batch for the production of a refractory magnesia-carbon product or a refractory alumina-magnesia-carbon product, a process for the production of a refractory magnesia-carbon product or a refractory alumina-magnesia-carbon product, a refractory magnesia-carbon product or a refractory alumina-magnesia-carbon product as well as the use of a magnesia-carbon product or a refractory alumina-magnesia-carbon product.
    Type: Application
    Filed: June 29, 2015
    Publication date: October 26, 2017
    Inventors: Clemens Ebner, Bernd Neubauer, Andreas Rief, Alexander Maranitsch, Bernd Trummer
  • Patent number: 8962008
    Abstract: The present invention relates to a novel polymeric material with enhanced hydrophilicity for medical use comprising a biocompatible polyester material selected from the group consisting of poly(hydroxyalkanoate)s, poly(lactic acid)s, poly(glycolic acid)s, poly(caprolactone)s and copolymers and blends thereof, wherein the biocompatible polyester material is crosslinked with a functionalized poly(alkylene oxide) having at least two functional groups independently selected from the group consisting of azido-formate and alkanoyl azide. The novel polymeric material with enhanced hydrophilicity is useful as a biocompatible material in a variety of medical applications, including medical implants, bioresorbable implants, tissue engineering, and controlled release.
    Type: Grant
    Filed: June 20, 2012
    Date of Patent: February 24, 2015
    Assignees: Technische Universitat Graz, Medical University of Graz MUG, AT&S Austria Technologie & Systemtechnik Aktiengesellschaft, Herabus Medical GmbH
    Inventors: Frank Wiesbrock, Clemens Ebner, Franz Stelzer, Annelie-Martina Weinberg, Klaus-Dieter Kühn
  • Publication number: 20140228449
    Abstract: The present invention relates to a novel polymeric material with enhanced hydrophilicity for medical use comprising a biocompatible polyester material selected from the group consisting of poly(hydroxyalkanoate)s, poly(lactic acid)s, poly(glycolic acid)s, poly(caprolactone)s and copolymers and blends thereof, wherein the biocompatible polyester material is crosslinked with a functionalized poly(alkylene oxide) having at least two functional groups independently selected from the group consisting of azido-formate and alkanoyl azide. The novel polymeric material with enhanced hydrophilicity is useful as a biocompatible material in a variety of medical applications, including medical implants, bioresorbable implants, tissue engineering, and controlled release.
    Type: Application
    Filed: June 20, 2012
    Publication date: August 14, 2014
    Applicant: Technische Universitat Graz
    Inventors: Frank Wiesbrock, Clemens Ebner, Franz Stelzer, Annelie-Martina Weinberg, Klaus-Dieter Kühn